- From: Michael Miller <Michael.Miller@systemsbiology.org>
- Date: Mon, 10 Sep 2012 11:20:18 -0700
- To: Helena Deus <helenadeus@gmail.com>, Michel Dumontier <michel.dumontier@gmail.com>
- Cc: "Lin MD, Simon" <LINMD.SIMON@mcrf.mfldclin.edu>, ilpuccio.febo@gmail.com, expressionrdf@googlegroups.com, HCLS <public-semweb-lifesci@w3.org>, chisato-yamasaki@aist.go.jp
- Message-ID: <fef40dec7195727116b876369d44a73b@mail.gmail.com>
hi all, '“genome profiling” can also include the work of SNP identification etc.' i think looking at SNP identification is not a bad idea but even tho the same technology is used, in the end, the analysis is very different for both microarray and NGS snp identification than gene expression. just because the initial processing is similar, from a systems biology perspective, i don't really see a difference between 'genome profiling' and any -omics technology, where as using either microarrays or NGS to do gene expression studies is a distinct -omics as is SNP identification. 'both the term "gene expression" and the note itself are still associated with microarrays' this is not the case that i've seen, particularly in the context of a gene expression study. in TCGA, microarray based studies are slowly but surely being replaced by NGS gene expression studies and there has been no confusion. so for the note i think it will be much clearer to stay with gene expression and, as part of the systems biology working group, begin to move into these other -omics and how they can be used together to form a model. my 2˘, michael Michael Miller Software Engineer Institute for Systems Biology *From:* Helena Deus [mailto:helenadeus@gmail.com] *Sent:* Monday, September 10, 2012 10:01 AM *To:* Michel Dumontier *Cc:* Lin MD, Simon; ilpuccio.febo@gmail.com; expressionrdf@googlegroups.com; Michael Miller; HCLS; chisato-yamasaki@aist.go.jp *Subject:* Re: Expression RDF note thumbs up for "genome profiling" :) Helena F. Deus, PhD Unit Leader, Bioinformatics and Computational Biology Digital Enterprise Research Institute helena.deus@deri.org +353 91 495 270 On Sep 10, 2012, at 5:48 PM, Michel Dumontier wrote: Lin et al, expanding the scope to genomic profiling is an excellent and most welcome idea :) Scott - ok, then let's plan asia-europe and europe-americas calls. m. On Tue, Sep 11, 2012 at 1:37 AM, Lin MD, Simon < LINMD.SIMON@mcrf.mfldclin.edu> wrote: In light of NGS, shall we call it “genome profiling” to expand the work from ‘gene expression’? “genome profiling” can also include the work of SNP identification etc. -Simon *From:* Ra [mailto:ilpuccio.febo@gmail.com] *Sent:* Monday, September 10, 2012 11:35 AM *To:* Helena Deus *Cc:* Michel Dumontier; expressionrdf@googlegroups.com; Michael Miller; HCLS; chisato-yamasaki@aist.go.jp; Lin MD, Simon *Subject:* Re: Expression RDF note I can provide support for ngs. Currently I'm working on RnaSeq and our lab start from raw samples so I have the chance, I'm sure you too, to have an overview of the compete production of the data. To better understand my topics the page of the lab http://www.ingm.org/research/researchprojects/ibif you have any question please feel free to drop an email. I also worked on bacteria assembly SNP and ancient DNA. Chip seq is in plan. Il giorno 10/set/2012 18:24, "Helena Deus" <helenadeus@gmail.com> ha scritto: All, we discussed, at some point, that NGS data should be supported by the note. should we call it transcriptomic representation note instead? both the term "gene expression" and the note itself are still associated with microarrays, a completelly different strategy from NGS. but both are related to transcriptomics. Best Lena Helena F. Deus, PhD Unit Leader, Bioinformatics and Computational Biology Digital Enterprise Research Institute helena.deus@deri.org +353 91 495 270 On Sep 10, 2012, at 5:13 PM, Lin MD, Simon wrote: The W3C gene expression note is also of interest to me. I would be happy to contribute a use case of Gene Screening from Next Generation Sequencing. What is the time line of this project? I might not be able to work on it much till the end of Sept. With regard to meetings, I am open and flexible. Thanks! -Simon ================================================== Simon Lin, MD | Director, Biomedical Informatics Research Center | Marshfield Clinic Research Foundation | 1000 N Oak Ave, Marshfield, WI 54449 | 715-221-7299 | Lin.Simon@mcrf.mfldclin.edu | www.marshfieldclinic.org/birc For scheduling assistance, please contact Crystal Gumz, Administrative Secretary | 715-221-6403 |gumz.crystal@mcrf.mfldclin.edu *From:* Michel Dumontier [mailto:michel.dumontier@gmail.com] *Sent:* Monday, September 10, 2012 10:56 AM *To:* Michael Miller *Cc:* HCLS; expressionrdf@googlegroups.com; ilpuccio.febo@gmail.com; chisato-yamasaki@aist.go.jp *Subject:* Expression RDF note Hi, While I was at a very productive BioHackathon, Raoul and Chisato (cc'd) expressed interest in the W3C gene expression note. https://docs.google.com/document/d/1A5-3tOsifPWPpETBKU-ZA9d7O7wK_nBzTFUBEe-0Bzo/edit?authkey=CK-y8Y8C&authkey=CK-y8Y8C I'm now teaching every Monday between 10am and 11:30am EDT, so I would prefer that the time be changed for me to participate. However, with participants in North America, Europe and Japan, our scheduling may become significantly more challenging. Suggestions? m. -- Michel Dumontier Associate Professor of Bioinformatics, Carleton University Chair, W3C Semantic Web for Health Care and the Life Sciences Interest Group http://dumontierlab.com ------------------------------ The contents of this message may contain private, protected and/or privileged information. If you received this message in error, you should destroy the e-mail message and any attachments or copies, and you are prohibited from retaining, distributing, disclosing or using any information contained within. Please contact the sender and advise of the erroneous delivery by return e-mail or telephone. Thank you for your cooperation. ------------------------------ The contents of this message may contain private, protected and/or privileged information. If you received this message in error, you should destroy the e-mail message and any attachments or copies, and you are prohibited from retaining, distributing, disclosing or using any information contained within. Please contact the sender and advise of the erroneous delivery by return e-mail or telephone. Thank you for your cooperation. -- Michel Dumontier Associate Professor of Bioinformatics, Carleton University Chair, W3C Semantic Web for Health Care and the Life Sciences Interest Group http://dumontierlab.com
Received on Monday, 10 September 2012 18:26:44 UTC